Haru Morita, President and CEO of Modalis Therapeutics Corporation, is scheduled to give a speech regarding
“The frontline of Gene editing and Modalis’ novel gene modulation therapies”
at the CBI Society Lecture hosted by The Chem-Bio Informatics Society (CBI Society) on November 19.

For more details, please see the following link.
https://cbi-society.org/home/documents/seminar/2021to24/20211119.html

※ The link will take you to a web page in Japanese.